カナグリフロジンの世界市場 2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Canagliflozin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-02061 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・治療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、カナグリフロジンの世界市場を広く調査・分析し、今後の市場展望をまとめております。カナグリフロジンの種類別市場規模（100mg、300mg）、用途別市場規模（糖尿病、心臓病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Janssen Pharmaceuticals、Hinye、Mitsubishi Tanabe Pharma、Hansoh Pharma ・地域別グローバル市場分析 2015年-2020年 ・カナグリフロジンの北米市場（アメリカ、カナダ、メキシコ） ・カナグリフロジンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・カナグリフロジンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・カナグリフロジンの南米市場（ブラジル、アルゼンチン） ・カナグリフロジンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：100mg、300mg ・用途別分析：糖尿病、心臓病、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Canagliflozin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Canagliflozin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Canagliflozin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Canagliflozin market has been segmented into
100mg
300mg

By Application, Canagliflozin has been segmented into:
Diabetes
Heart Disease
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Canagliflozin market presented in the report. This section sheds light on the sales growth of different regional and country-level Canagliflozin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Canagliflozin market.

The report offers in-depth assessment of the growth and other aspects of the Canagliflozin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Canagliflozin Market Share Analysis
Canagliflozin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Canagliflozin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Canagliflozin sales, revenue and market share for each player covered in this report.

The major players covered in Canagliflozin are:
Janssen Pharmaceuticals
Hinye
Mitsubishi Tanabe Pharma
Hansoh Pharma

Among other players domestic and global, Canagliflozin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Canagliflozin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Canagliflozin, with price, sales, revenue and global market share of Canagliflozin in 2018 and 2019.
Chapter 3, the Canagliflozin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Canagliflozin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Canagliflozin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Canagliflozin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Canagliflozin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Canagliflozin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 100mg
1.2.3 300mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Canagliflozin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetes
1.3.3 Heart Disease
1.3.4 Others
1.4 Overview of Global Canagliflozin Market
1.4.1 Global Canagliflozin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Janssen Pharmaceuticals
2.1.1 Janssen Pharmaceuticals Details
2.1.2 Janssen Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Janssen Pharmaceuticals SWOT Analysis
2.1.4 Janssen Pharmaceuticals Product and Services
2.1.5 Janssen Pharmaceuticals Canagliflozin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hinye
2.2.1 Hinye Details
2.2.2 Hinye Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hinye SWOT Analysis
2.2.4 Hinye Product and Services
2.2.5 Hinye Canagliflozin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mitsubishi Tanabe Pharma
2.3.1 Mitsubishi Tanabe Pharma Details
2.3.2 Mitsubishi Tanabe Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mitsubishi Tanabe Pharma SWOT Analysis
2.3.4 Mitsubishi Tanabe Pharma Product and Services
2.3.5 Mitsubishi Tanabe Pharma Canagliflozin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Hansoh Pharma
2.4.1 Hansoh Pharma Details
2.4.2 Hansoh Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Hansoh Pharma SWOT Analysis
2.4.4 Hansoh Pharma Product and Services
2.4.5 Hansoh Pharma Canagliflozin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Canagliflozin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Canagliflozin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Canagliflozin Manufacturer Market Share in 2019
3.3.2 Top 6 Canagliflozin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Canagliflozin Sales, Revenue and Market Share by Regions
4.1.1 Global Canagliflozin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Canagliflozin Revenue and Market Share by Regions (2015-2020)
4.2 North America Canagliflozin Sales and Growth Rate (2015-2020)
4.3 Europe Canagliflozin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Canagliflozin Sales and Growth Rate (2015-2020)
4.5 South America Canagliflozin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Canagliflozin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Canagliflozin Sales, Revenue and Market Share by Country
5.1.1 North America Canagliflozin Sales and Market Share by Country (2015-2020)
5.1.2 North America Canagliflozin Revenue and Market Share by Country (2015-2020)
5.2 United States Canagliflozin Sales and Growth Rate (2015-2020)
5.3 Canada Canagliflozin Sales and Growth Rate (2015-2020)
5.4 Mexico Canagliflozin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Canagliflozin Sales, Revenue and Market Share by Country
6.1.1 Europe Canagliflozin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Canagliflozin Revenue and Market Share by Country (2015-2020)
6.2 Germany Canagliflozin Sales and Growth Rate (2015-2020)
6.3 UK Canagliflozin Sales and Growth Rate (2015-2020)
6.4 France Canagliflozin Sales and Growth Rate (2015-2020)
6.5 Russia Canagliflozin Sales and Growth Rate (2015-2020)
6.6 Italy Canagliflozin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Canagliflozin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Canagliflozin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Canagliflozin Revenue and Market Share by Regions (2015-2020)
7.2 China Canagliflozin Sales and Growth Rate (2015-2020)
7.3 Japan Canagliflozin Sales and Growth Rate (2015-2020)
7.4 Korea Canagliflozin Sales and Growth Rate (2015-2020)
7.5 India Canagliflozin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Canagliflozin Sales and Growth Rate (2015-2020)
7.7 Australia Canagliflozin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Canagliflozin Sales, Revenue and Market Share by Country
8.1.1 South America Canagliflozin Sales and Market Share by Country (2015-2020)
8.1.2 South America Canagliflozin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Canagliflozin Sales and Growth Rate (2015-2020)
8.3 Argentina Canagliflozin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Canagliflozin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Canagliflozin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Canagliflozin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Canagliflozin Sales and Growth Rate (2015-2020)
9.3 Turkey Canagliflozin Sales and Growth Rate (2015-2020)
9.4 Egypt Canagliflozin Sales and Growth Rate (2015-2020)
9.5 South Africa Canagliflozin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Canagliflozin Sales and Market Share by Type (2015-2020)
10.2 Global Canagliflozin Revenue and Market Share by Type (2015-2020)
10.3 Global Canagliflozin Price by Type (2015-2020)
11 Global Canagliflozin Market Segment by Application
11.1 Global Canagliflozin Sales Market Share by Application (2015-2020)
11.2 Global Canagliflozin Revenue Market Share by Application (2015-2020)
11.3 Global Canagliflozin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Canagliflozin Sales, Revenue and Growth Rate (2021-2025)
12.2 Canagliflozin Market Forecast by Regions (2021-2025)
12.2.1 North America Canagliflozin Market Forecast (2021-2025)
12.2.2 Europe Canagliflozin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Canagliflozin Market Forecast (2021-2025)
12.2.4 South America Canagliflozin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Canagliflozin Market Forecast (2021-2025)
12.3 Canagliflozin Market Forecast by Type (2021-2025)
12.3.1 Global Canagliflozin Sales Forecast by Type (2021-2025)
12.3.2 Global Canagliflozin Market Share Forecast by Type (2021-2025)
12.4 Canagliflozin Market Forecast by Application (2021-2025)
12.4.1 Global Canagliflozin Sales Forecast by Application (2021-2025)
12.4.2 Global Canagliflozin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Canagliflozin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Canagliflozin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Canagliflozin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Janssen Pharmaceuticals Canagliflozin Major Business
Table 9. Janssen Pharmaceuticals Canagliflozin Total Revenue (USD Million) (2018-2019)
Table 10. Janssen Pharmaceuticals SWOT Analysis
Table 11. Janssen Pharmaceuticals Canagliflozin Product and Services
Table 12. Janssen Pharmaceuticals Canagliflozin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Hinye Basic Information, Manufacturing Base and Competitors
Table 14. Hinye Canagliflozin Major Business
Table 15. Hinye Canagliflozin Total Revenue (USD Million) (2018-2019)
Table 16. Hinye SWOT Analysis
Table 17. Hinye Canagliflozin Product and Services
Table 18. Hinye Canagliflozin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Mitsubishi Tanabe Pharma Canagliflozin Major Business
Table 21. Mitsubishi Tanabe Pharma Canagliflozin Total Revenue (USD Million) (2018-2019)
Table 22. Mitsubishi Tanabe Pharma SWOT Analysis
Table 23. Mitsubishi Tanabe Pharma Canagliflozin Product and Services
Table 24. Mitsubishi Tanabe Pharma Canagliflozin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
Table 26. Hansoh Pharma Canagliflozin Major Business
Table 27. Hansoh Pharma Canagliflozin Total Revenue (USD Million) (2018-2019)
Table 28. Hansoh Pharma SWOT Analysis
Table 29. Hansoh Pharma Canagliflozin Product and Services
Table 30. Hansoh Pharma Canagliflozin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Canagliflozin Sales by Manufacturer (2018-2019) (K Units)
Table 32. Global Canagliflozin Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Canagliflozin Sales by Regions (2015-2020) (K Units)
Table 34. Global Canagliflozin Sales Market Share by Regions (2015-2020)
Table 35. Global Canagliflozin Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Canagliflozin Sales by Countries (2015-2020) (K Units)
Table 37. North America Canagliflozin Sales Market Share by Countries (2015-2020)
Table 38. North America Canagliflozin Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Canagliflozin Revenue Market Share by Countries (2015-2020)
Table 40. Europe Canagliflozin Sales by Countries (2015-2020) (K Units)
Table 41. Europe Canagliflozin Sales Market Share by Countries (2015-2020)
Table 42. Europe Canagliflozin Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Canagliflozin Sales by Regions (2015-2020) (K Units)
Table 44. Asia-Pacific Canagliflozin Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Canagliflozin Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Canagliflozin Sales by Countries (2015-2020) (K Units)
Table 47. South America Canagliflozin Sales Market Share by Countries (2015-2020)
Table 48. South America Canagliflozin Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Canagliflozin Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Canagliflozin Sales by Countries (2015-2020) (K Units)
Table 51. Middle East & Africa Canagliflozin Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Canagliflozin Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Canagliflozin Revenue Market Share by Countries (2015-2020)
Table 54. Global Canagliflozin Sales by Type (2015-2020) (K Units)
Table 55. Global Canagliflozin Sales Share by Type (2015-2020)
Table 56. Global Canagliflozin Revenue by Type (2015-2020) (USD Million)
Table 57. Global Canagliflozin Revenue Share by Type (2015-2020)
Table 58. Global Canagliflozin Sales by Application (2015-2020) (K Units)
Table 59. Global Canagliflozin Sales Share by Application (2015-2020)
Table 60. Global Canagliflozin Sales Forecast by Regions (2021-2025) (K Units)
Table 61. Global Canagliflozin Market Share Forecast by Regions (2021-2025)
Table 62. Global Canagliflozin Sales Forecast by Type (2021-2025) (K Units)
Table 63. Global Canagliflozin Market Share Forecast by Type (2021-2025)
Table 64. Global Canagliflozin Sales Forecast by Application (2021-2025)
Table 65. Global Canagliflozin Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Canagliflozin Picture
Figure 2. Global Sales Market Share of Canagliflozin by Type in 2019
Figure 3. 100mg Picture
Figure 4. 300mg Picture
Figure 5. Canagliflozin Sales Market Share by Application in 2018
Figure 6. Diabetes Picture
Figure 7. Heart Disease Picture
Figure 8. Others Picture
Figure 9. Global Canagliflozin Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Canagliflozin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Canagliflozin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Canagliflozin Sales Market Share by Manufacturer in 2019
Figure 30. Global Canagliflozin Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Canagliflozin Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Canagliflozin Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Canagliflozin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Canagliflozin Revenue Market Share by Regions (2015-2020)
Figure 37. Global Canagliflozin Revenue Market Share by Regions in 2018
Figure 38. North America Canagliflozin Sales and Growth Rate (2015-2020)
Figure 39. Europe Canagliflozin Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Canagliflozin Sales and Growth Rate (2015-2020)
Figure 41. South America Canagliflozin Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Canagliflozin Sales and Growth Rate (2015-2020)
Figure 43. North America Canagliflozin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Canagliflozin Sales Market Share by Countries (2015-2020)
Figure 45. North America Canagliflozin Sales Market Share by Countries in 2018
Figure 46. North America Canagliflozin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Canagliflozin Revenue Market Share by Countries in 2018
Figure 48. United States Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Canagliflozin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Canagliflozin Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Canagliflozin Revenue Market Share by Countries in 2019
Figure 54. Germany Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Canagliflozin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Canagliflozin Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Canagliflozin Revenue Market Share by Regions 2019
Figure 62. China Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Canagliflozin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Canagliflozin Sales Market Share by Countries in 2019
Figure 69. South America Canagliflozin Revenue Market Share by Countries in 2019
Figure 70. Brazil Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Canagliflozin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Canagliflozin Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Canagliflozin Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Canagliflozin Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Canagliflozin Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Canagliflozin Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Canagliflozin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Canagliflozin Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Canagliflozin Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Canagliflozin Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Canagliflozin Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Canagliflozin Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel

---